Apparent potentiating effect of a second dose of drug

Potential Risks of Microplastic Fomites to Aquatic Organisms with Special Emphasis on Polyethylene-Microplastic-Glyphosate Exposure Case in Aquacultured Shrimp

Plastic litter is increasingly becoming pervasive in aquatic environments, characterized by circulatory patterns between different compartments and continual loading with new debris. Microplastic pollution can cause a variety of effects on aquatic organisms. This review presents the current knowledge of microplastics distribution and sorption capacity, reflecting on possible bioaccumulation and health effects in aquatic organisms. A model case study reveals the fate and toxic effects of glyphosate, focusing on the simultaneous exposure of aquacultured shrimp to polyethylene and glyphosate and their contact route and on the potential effects on their health and the risk for transmission of the contaminants. The toxicity and bioaccumulation of glyphosate-sorbed polyethylene microplastics in shrimp are not well understood, although individual effects have been studied extensively in various organisms. We aim to delineate this knowledge gap by compiling current information regarding the co-exposure to polyethylene microplastic adsorbed with glyphosate to assist in the assessment of the possible health risks to aquacultured shrimp and their consumers.

Pharmacokinetic-pharmacodynamic modelling: history and perspectives

A major goal in clinical pharmacology is the quantitative prediction of drug effects. The field of pharmacokinetic-pharmacodynamic (PK/PD) modelling has made many advances from the basic concept of the dose-response relationship to extended mechanism-based models. The purpose of this article is to review, from a historical perspective, the progression of the modelling of the concentration-response relationship from the first classic models developed in the mid-1960s to some of the more sophisticated current approaches. The emphasis is on general models describing key PD relationships, such as: simple models relating drug dose or concentration in plasma to effect, biophase distribution models and in particular effect compartment models, models for indirect mechanism of action that involve primarily the modulation of endogenous factors, models for cell trafficking and transduction systems. We show the evolution of tolerance and time-variant models, non- and semi-parametric models, and briefly discuss population PK/PD modelling, together with some example of more recent and complex pharmacodynamic models for control system and nonlinear HIV-1 dynamics. We also discuss some future possible directions for PK/PD modelling, report equations for general classes of novel semi-parametric models, as well as describing two new classes, additive or set-point, of regulatory, additive feedback models in their direct and indirect action variants.